ESPR
Esperion Therapeutics Inc
Price:  
2.21 
USD
Volume:  
8,687,293.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ESPR Relative Valuation

-643.5%
Upside

As of 2024-06-22, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (12.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.21 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -643.5%.

The range of the Relative Valuation is (10.22) - (12.63) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 16.9x - 29.7x 28.3x
Forward P/E multiples 22.4x - 27.7x 24.3x
Fair Price (10.22) - (12.63) (12.01)
Upside -562.5% - -671.6% -643.5%
2.21 USD
Stock Price
(12.01) USD
Fair Price

ESPR Relative Valuation - Historical P/E Data

Date P/E
2024-06-21 -4.84
2024-06-20 -5.01
2024-06-18 -5.96
2024-06-17 -6.28
2024-06-14 -6.55
2024-06-13 -6.37
2024-06-12 -6.33
2024-06-11 -6.35
2024-06-10 -6.37
2024-06-07 -6.13
2024-06-06 -5.41
2024-06-05 -5.10
2024-06-04 -4.93
2024-06-03 -4.90
2024-05-31 -4.73
2024-05-30 -5.01
2024-05-29 -4.75
2024-05-28 -4.60
2024-05-24 -4.66
2024-05-23 -4.93
2024-05-22 -5.21
2024-05-21 -5.28
2024-05-20 -5.43
2024-05-17 -5.17
2024-05-16 -5.67
2024-05-15 -5.04
2024-05-14 -4.77
2024-05-13 -4.88
2024-05-10 -4.80
2024-05-09 -4.58
2024-05-08 -4.47
2024-05-07 -5.19
2024-05-06 -4.64
2024-05-03 -4.55
2024-05-02 -4.51
2024-05-01 -4.47
2024-04-30 -4.31
2024-04-29 -4.36
2024-04-26 -4.16
2024-04-25 -4.36
2024-04-24 -4.66
2024-04-23 -4.58
2024-04-22 -4.18
2024-04-19 -4.27
2024-04-18 -4.09
2024-04-17 -4.03
2024-04-16 -4.18
2024-04-15 -4.24
2024-04-12 -4.69
2024-04-11 -5.06